Clinical trial announcements, orphan-drug designation and more: check out our round-up of the biggest news from the neuroscience and neurology industries this week.
Browsing: Cerebrovascular disease
According to a recent study, an anti-inflammatory drug given to patients in the early stages of a stroke could reduce harmful inflammation.
In this research article from Journal of Comparative Effectiveness Research find out more about a newly proposed stroke severity scale to improve patient care and rehabilitation.
Researchers from Japan have revealed a new neural pathway that links stress with organ dysfunction.
Preliminary findings suggest that some cell therapies may be relatively safe and effective, but larger double-blinded placebo-controlled studies are needed to establish the long-term risks and benefits.
This systematic review provides a summary of the blood protein biomarkers that have been studied for the diagnosis of acute ischemic stroke.
A biomarker to aid in the diagnosis of ischemic stroke and its causes would be of value in acute clinical practice. It could have applications to aid in acute stroke treatment decisions for tissue plasminogen activator and/or the triage to endovascular therapy. This review provides an overview of RNA as a novel biomarker for the diagnosis and assessment of ischemic stroke.
This year’s WBD theme is ‘Stroke is a brain attack – prevent it and treat it’ – in this interview, we learn more about WBD and what will the WFN be doing to mark this.
A project aimed at helping people who have had a stroke, is among the programs approved today by the governing Board of CIRM.
Researchers have provided evidence indicating that patients with hypertension suffer from more severe Parkinson’s disease than those with normal blood pressure.